A new Harvard study reveals that the brains of Alzheimer's patients are deficient in lithium because the element gets trapped by amyloid plaques. In mouse models, a low dose of a special form called lithium orotate bypassed these traps, successfully reducing plaques and inflammation while restoring memory. This research suggests that addressing this lithium deficiency could be a promising new approach to treating Alzheimer's disease.